Prot #AZA-MDS-003: A Phase 3, Multicenter, Randomized, Doubleblind Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo Plus Best Supportive Care In Subjects with Red Blood Cell Transfusion-Dependent Anemia

Project: Research project

Project Details

StatusFinished
Effective start/end date9/17/139/17/19

Funding

  • Celgene Corporation (Prot #AZA-MDS-003)